The DOI matches its Crossref record; 291 of the 293 references it cites were found in a registry or an index.
Drug-Induced Photosensitivity—An Update: Culprit Drugs, Prevention and Management
Abstract
Photosensitive drug eruptions are cutaneous adverse events due to exposure to a medication and either ultraviolet or visible radiation. In this review, the diagnosis, prevention and management of drug-induced photosensitivity is discussed. Diagnosis is based largely on the history of drug intake and the appearance of the eruption primarily affecting sun-exposed areas of the skin. This diagnosis can also be aided by tools such as phototesting, photopatch testing and rechallenge testing. The mainstay of management is prevention, including informing patients of the possibility of increased photosensitivity as well as the use of appropriate sun protective measures. Once a photosensitivity reaction has occurred, it may be necessary to discontinue the culprit medication and treat the reaction with corticosteroids. For certain medications, long-term surveillance may be indicated because of a higher risk of developing melanoma or squamous cell carcinoma at sites of earlier photosensitivity reactions. A large number of medications have been implicated as causes of photosensitivity, many with convincing clinical and scientific supporting evidence. We review the medical literature regarding the evidence for the culpability of each drug, including the results of phototesting, photopatch testing and rechallenge testing. Amiodarone, chlorpromazine, doxycycline, hydrochlorothiazide, nalidixic acid, naproxen, piroxicam, tetracycline, thioridazine, vemurafenib and voriconazole are among the most consistently implicated and warrant the most precaution by both the physician and patient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The use of photosensitizing drugs may also increase patients’ susceptibility to skin photodamage”
From Photoprotection for skin of color (2022) · cites this paper as [139]
In the citing paper
“drugs that have been implicated include tetracycline, doxycycline, hydrochlorothiazide (HCTZ), amiodarone, naproxen, piroxicam, chlorpromazine, and thioridazine, among others [139].”
From Photoprotection for skin of color (2022) · cites this paper as [139]
Citations
Cites
Structure-activity and structure-side-effect relationships for the quinolone antibacterials
Domagala, J. M. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.4.685 · Cited by 681
Seo, Y., Baba, H., Fukuda, T., Takashima, M., & Sugimachi, K. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000515)88:10<2210::aid-cncr3>3.0.co;2-i · Cited by 406
Side effects of long-term amiodarone therapy.
Harris, L., McKenna, W. J., Rowland, E., Holt, D. W., Storey, G. C., & Krikler, D. M. (1983) · Circulation · doi:10.1161/01.cir.67.1.45 · Cited by 358
Cutaneous photosensitivity diseases induced by exogenous agents
Gould, J. W., Mercurio, M. G., & Elmets, C. A. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)91271-1 · Cited by 300
Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma
Lacouture, M. E., Duvic, M., Hauschild, A., Prieto, V. G., Robert, C., Schadendorf, D., Kim, C. C., McCormack, C. J., Myskowski, P. L., Spleiss, O., et al. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0333 · Cited by 218
Infectious Diseases: Safety Concerns with Fluoroquinolones
Mehlhorn, A. J., & Brown, D. A. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k347 · Cited by 204
Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses
COLLINS, P., & FERGUSON, J. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb16955.x · Cited by 199
Emanuel Miller. M.A. Cantab., F.R.C.P., D.P.M.
Cantab, M. A. (1970) · PubMed · Cited by 198
Drug-Induced Photosensitivity: Culprit Drugs, Management and Prevention
Drucker, A. M., & Rosen, C. F. (2011) · Drug Safety · doi:10.2165/11592780-000000000-00000 · Cited by 190
Self-citationSKIN CHANGES IN PATIENTS TREATED WITH 5-FLUOROURACIL.
FALKSON, G., & SCHULZ, E. J. (1962) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1962.tb13497.x · Cited by 175
Cited by
Drug‐induced photosensitivity: culprit drugs, potential mechanisms and clinical consequences
Hofmann, G., & Weber, B. (2021) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14314 · Cited by 122
Impact of Cytochrome P450 Enzymes on the Phase I Metabolism of Drugs
Iacopetta, D., Ceramella, J., Catalano, A. A., Scali, E., Scumaci, D., PELLEGRINO, M. A., Aquaro, S., Saturnino, C., & Sinicropi, M. S. (2023) · Applied Sciences · doi:10.3390/app13106045 · Cited by 99
Pucek, A., Tokarek, B., Waglewska, E., & Bazylińska, U. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060587 · Cited by 74
“Substances are considered as photosensitive when they can absorb visible or UV radiation [123].”
BackgroundPhotoprotection for skin of color
Tsai, J., & Chien, A. L. (2022) · American Journal of Clinical Dermatology · doi:10.1007/s40257-021-00670-z · Cited by 63
“The use of photosensitizing drugs may also increase patients’ susceptibility to skin photodamage, and drugs that have been implicated include tetracycline, doxycycline, hydrochlorothiazide (HCTZ), amiodarone, naproxen, piroxicam, chlorpromazine, and thioridazine, among others [139].”
BackgroundBartolomeo, L. D., Irrera, N., Campo, G. M., Borgia, F., Motolese, A., Vaccaro, F., Squadrito, F., Altavilla, D., Condorelli, A. G., Motolese, A., et al. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.876695 · Cited by 62
Metadata
- Authors
- Blakely, K. M., Drucker, A. M., & Rosen, C. F.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Rosen, Cheryl F.
- Venue
- Drug Safety
- Published
- 2019-03-19
- Volume
- 42
- Issue
- 7
- Pages
- 827-847
- ISSN
- 0114-5916 (ISSN-L)
- 1179-1942
- OpenAlex
- W2924627121
- Cited by
- 122
- References
- 293
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 16 · 2023: 20 · 2022: 28 · 2021: 13 · 2020: 10 · 2019: 2
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Health Sciences › Medicine › Dermatology › Skin Protection and Aging
- Keywords
- drug-induced photosensitivity, drug-induced skin reaction, phototesting, photopatch testing, sun protection, corticosteroid therapy, melanoma risk, squamous cell carcinoma risk, amiodarone, chlorpromazine, doxycycline, hydrochlorothiazide, nalidixic acid, naproxen, piroxicam, tetracycline, thioridazine, vemurafenib, voriconazole
- MeSH terms
- Drug Eruptions, Humans, Sunlight, Dermatitis, Phototoxic, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drug-Induced Photosensitivity—An Update: Culprit Drugs, Prevention and Management. https://app.cochat.ai/papers/10.1007/s40264-019-00806-5
- The paper
- Blakely, K. M., Drucker, A. M., & Rosen, C. F. (2019). Drug-Induced Photosensitivity—An Update: Culprit Drugs, Prevention and Management. Drug Safety. https://doi.org/10.1007/s40264-019-00806-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.